EUVIMEDEUVIMED entdecken
Open Access

PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1 + CD8 + T cells

Jun Deng, Junling Zhu, Xiaoyue Jiang, Chao Yao, Haifeng Chen, Yanjie Ding, Peng Niu, Qian Chen, Huihua Ding, Nan Shen

Theranostics · 31.03.2025 · 15 (11) · 5029-5044

DOI: 10.7150/thno.107418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 31.03.2025. Verfasst von Jun Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Rheumatology, Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Lupus Nephritis, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesAnimalsMiceHumansFemaleDisease Models, AnimalB7-H1 AntigenSTAT1 Transcription FactorMaleMice, Inbred NZBKidney

Stichwörter der Autor:innen

Lupus nephritisPD-1+CD8+ T cellTCR clonalityscRNA-seq

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenPDCD1 protein, humanSTAT1 Transcription FactorPdcd1 protein, mouse

Autor:innen und Institutionen

  • Shanghai Institute of Rheumatology, Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Rheumatology and Immunology, Huaihe Hospital of Henan University, Kaifeng, 475000, Henan, China.
  • Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.

Zitieren

APA

Deng, J., Zhu, J., Jiang, X., Yao, C., Chen, H., Ding, Y., Niu, P., Chen, Q., Ding, H., & Shen, N. (2025). PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1 + CD8 + T cells. Theranostics, 15(11), 5029-5044. https://doi.org/10.7150/thno.107418

Vancouver

Deng J, Zhu J, Jiang X, Yao C, Chen H, Ding Y, et al. PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1 + CD8 + T cells. Theranostics. 2025;15(11):5029-5044. doi:10.7150/thno.107418

BibTeX
@article{Deng2025,
  author = {Deng, Jun and Zhu, Junling and Jiang, Xiaoyue and Yao, Chao and Chen, Haifeng and Ding, Yanjie and Niu, Peng and Chen, Qian and Ding, Huihua and Shen, Nan},
  title = {PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1 + CD8 + T cells},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {5029--5044},
  doi = {10.7150/thno.107418}
}
Kostenlos starten →